Introduction
Endobronchial tuberculosis, while relatively common before the advent of effective antituberculosis chemotherapy,' is infrequently encountered nowa- days. The pathogenesis of the disease is unclear. It may result from rupture of caseous material from lymph nodes, lymphatic spread along the bronchial tree, haematogenous spread or direct implantation of tubercle bacilli from parenchymal focus. The presentation of the disease is variable. It may be acute, simulating asthma2 or foreign body aspiration,3 insidious, simulating lung cancer,4 or delayed, appearing for the first time long after completion of antituberculosis treatment.5 The course and prognosis of the disease is as variable, ranging from complete clearance to severe bronchostenosis. 6 Although corticosteroid has been given empirically in an attempt to prevent fibrosis, the value of corticosteroid in the treatment of endobronchial tuberculosis is uncertain. Because 
Results
The final outcome of the endobronchial lesions is summarized in Table II 
